期刊文献+

非损伤性功能成像技术:正电子发射断层扫描术、磁共振波谱分析和动态对比增强磁共振影像学(英文)

Noninvasive functional imaging techniques: positron emission tomography (PET), magnetic resonance spectroscopy (MRS), dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI)
下载PDF
导出
摘要 当前在医药工业中越来越关注将非损伤性功能成像技术作为潜在的病人体内药物作用早期检测技术。正电子发射断层扫描术可监测组织中放射标记的药物和其代谢物的绝对浓度,或者是特殊受体的配体浓度,且可以三维直观地显示它们在体内的分布。磁共振波谱分析可监测体内未标记药物的代谢转化。动态对比增强磁共振影像学可显示小分子、亲水的造影剂在血浆与组织细胞间隙间的即时分布,并可以用来检测抗血管或血管生成的化合物的作用。 In the pharmaceutical industry, there is currently increasing interest in noninvasive functional imaging techniques as potential early indicators of drug effects in patients. PET allows one to monitor absolute concentrations of radiolabeled drugs and metabolites, or of ligands to specific receptors, in tissues, and to visualize their distribution three-dimensionally. MRS is capable of monitoring metabolic conversions in vivo without labeling. DCE-MRI shows the distribution of small-molecular, hydrophilic weight contrast agents between blood plasma and interstitial space in tissue in real time and can be used to detect effects of antivascular or anti-angiogenic compounds.
机构地区 Genentech Inc.
出处 《中国临床药理学与治疗学》 CAS CSCD 2007年第11期1295-1298,共4页 Chinese Journal of Clinical Pharmacology and Therapeutics
  • 相关文献

参考文献7

  • 1Weber WA. Use of PET for monitoring cancer therapy and for prediction outcome[J]. J Nucl Med, 2005;49:983-995.
  • 2Coimbm A, Williams DS, Hostetler ED. The role of MRI and PET/SPECT in Alzheimer's disease[J]. Curr Top Med Chem, 2006;6:629 - 647.
  • 3Brooks DJ. Positron emission tomography and single-photon emission computed tomography in central nervous system drug development [ J ]. NeurRx, 2005 ; 2 : 226 - 236.
  • 4Port RE, Wolf W. Noninvasive methods to study drug distribution[J]. Invest New Drugs, 2003;21 : 157 - 168.
  • 5Port R, Hanisch F, Becker M, et al. Local disposition kinetics of floxuridine after intratumoral and subcutaneous injection as monitored by 19F-nuclear magnetic resonance spectroscopy in vivo[J]. Cancer Chemother Pharmacol, 1999;44:65- 73.
  • 6Gillies R J, Morse DL. In vivo magnetic resonance spectroscopy in cancer[J]. Ann Rev Biomed Eng, 2005;7:287- 326.
  • 7O'Connor J, Jackson A, Parker G, et al. DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents[J]. Br J Cancer, 2007;96:189 - 195.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部